EUVIMED · CrossrefZeitschrift
Canadian Oncology Today
ISSN 2818-114X · Catalytic Health
Neueste Artikel
The Management of Advanced Anal Squamous Cell Carcinoma
Metastatic CRPC: Contemporary Therapeutic Options and Optimal Sequencing
Second-line Treatment Strategies in Biliary Tract Cancers
Integrative Medicine and Cancer: 5 Ways to Incorporate Integrative Oncology into Routine Clinical Practice
HIF Inhibition and Emerging Therapeutic Targets in Clear Cell Renal Cell Carcinoma
Current and Emerging Treatment Options for HER2‑Positive Gastroesophageal Cancer
Current Uses and Pitfalls of Liquid Biopsy in NSCLC
From Intractable to Treatable: Milestones and Horizons in the Management of HER2+ Breast Cancer
Survivorship Issues in Testicular Cancer
An Evolving Paradigm in Borderline Resectable and Locally Advanced Pancreatic Cancer: Current Strategies and Opportunities for the Future
First-line Treatment Selection for Advanced Hepatocellular Carcinoma
Prostate-specific Membrane Antigen (PSMA): A Diagnostic and Therapeutic Target in Advanced Prostate Cancer
Breast Cancer Survivorship
Tailored Approaches and Patient-centered Care: The Current Landscape of Neoadjuvant Therapy in Rectal Cancer
Antibody-drug Conjugates in The Management of Advanced Urothelial Carcinoma
The Role of ctDNA in Breast Cancer: Prognosis and Clinical Utility
Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?
Current Approaches and Future Directions for the Treatment of Solid Tumour Brain Metastases
The Role of Biomarkers in Upper Gastrointestinal Cancers
Advances in Adjuvant Therapy for High-Risk Breast Cancer: A Canadian Clinical Approach
Antibody-Drug Conjugates in Breast Cancer: Current Landscape and Future Targets
Perioperative Treatment Strategies for Lung Cancer in 2025: A Paradigm Shift
Treatment of Neuroendocrine Tumours: Approach of GEP-NETS
Management of Stage I–II Testicular Germ Cell Tumours: Current Treatment Paradigm and Future Perspectives
Small-Cell Lung Cancer: Integration of Radiation and Immunotherapy for All Stages
Treatment of dMMR Metastatic Colorectal Cancer in 2025
First-line Treatment Selection for Advanced Unresectable Biliary Tract Cancer
Original Research: Biomarker Testing in a Canadian Centre for Patients with Non‑small Cell Lung Cancer: Assessing Residual Risks
Current Issues in the Management of Sporadic Non-clear Cell Renal Cell Carcinoma (Non-ccRCC)
EUVIMED